103 related articles for article (PubMed ID: 9509974)
1. Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia.
Dictar M; Sinagra A; Verón MT; Luna C; Dengra C; De Rissio A; Bayo R; Ceraso D; Segura E; Koziner B; Riarte A
Bone Marrow Transplant; 1998 Feb; 21(4):391-3. PubMed ID: 9509974
[TBL] [Abstract][Full Text] [Related]
2. Chagas disease in bone marrow transplantation: an approach to preemptive therapy.
Altclas J; Sinagra A; Dictar M; Luna C; Verón MT; De Rissio AM; García MM; Salgueira C; Riarte A
Bone Marrow Transplant; 2005 Jul; 36(2):123-9. PubMed ID: 15908978
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole.
Altclas J; Sinagra A; Jaimovich G; Salgueira C; Luna C; Requejo A; Milovic V; De Rissio A; Feldman L; Riarte A
Transpl Infect Dis; 1999 Jun; 1(2):135-7. PubMed ID: 11428981
[TBL] [Abstract][Full Text] [Related]
4. CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
Soiffer RJ; Freedman AS; Neuberg D; Fisher DC; Alyea EP; Gribben J; Schlossman RL; Bartlett-Pandite L; Kuhlman C; Murray C; Freeman A; Mauch P; Anderson KC; Nadler LM; Ritz J
Bone Marrow Transplant; 1998 Jun; 21(12):1177-81. PubMed ID: 9674848
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients.
Riganti J; Maqueda MG; Piñero MC; Volonteri VI; Galimberti RL
Int J Dermatol; 2012 Jul; 51(7):829-34. PubMed ID: 22715827
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
Sobecks RM; Le Beau MM; Anastasi J; Williams SF
Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
[TBL] [Abstract][Full Text] [Related]
7. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation.
Hale GA; Tong X; Benaim E; Cunningham JM; Heslop HE; Horwiz EM; Leung W; Rochester RJ; Shearer PD; Srivastava DK; Woodard JP; Bowman LC
Bone Marrow Transplant; 2001 Jan; 27(2):155-62. PubMed ID: 11281384
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
11. BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective.
Cooney JP; Stiff PJ; Toor AA; Parthasarathy M
Biol Blood Marrow Transplant; 2003 Mar; 9(3):177-82. PubMed ID: 12652468
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada.
Schimmer AD; Jamal S; Messner H; Keating A; Meharchand J; Huebsch L; Walker I; Benger A; Gluck S; Smith A
Bone Marrow Transplant; 2000 Oct; 26(8):859-64. PubMed ID: 11081385
[TBL] [Abstract][Full Text] [Related]
13. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
14. [Hemolytic uremic syndrome after bone marrow transplantation].
Arai A; Sakamaki H; Tanikawa S; Akiyama H; Onozawa Y; Okamoto R; Maeda Y; Sasaki T; Kaku H; Tsuzuki S; Takamoto S
Rinsho Ketsueki; 1998 Jun; 39(6):422-6. PubMed ID: 9695669
[TBL] [Abstract][Full Text] [Related]
15. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
17. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
[TBL] [Abstract][Full Text] [Related]
18. Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation.
Siegert W; Beyer J; Kingreen D; Blasczyk R; Baurmann H; Schwella N; Schleicher J; Kirsch A; Huhn D
Bone Marrow Transplant; 1998 Sep; 22(6):579-83. PubMed ID: 9758347
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for Chagas' disease reactivation after heart transplantation.
Campos SV; Strabelli TM; Amato Neto V; Silva CP; Bacal F; Bocchi EA; Stolf NA
J Heart Lung Transplant; 2008 Jun; 27(6):597-602. PubMed ID: 18503957
[TBL] [Abstract][Full Text] [Related]
20. Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation.
Maldonado C; Albano S; Vettorazzi L; Salomone O; Zlocowski JC; Abiega C; Amuchastegui M; Córdoba R; Alvarellos T
J Heart Lung Transplant; 2004 Dec; 23(12):1345-8. PubMed ID: 15607662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
